Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus

被引：11

作者：

Pribut, Nicole ^{[1
]}

Kaiser, Thomas M. ^{[1
]}

Wilson, Robert J. ^{[1
]}

Jecs, Edgars ^{[1
]}

Dentmon, Zackery W. ^{[1
]}

Pelly, Stephen C. ^{[1
]}

Sharma, Savita ^{[1
]}

Bartsch, Perry W., III ^{[1
]}

Burger, Pieter B. ^{[1
]}

Hwang, Soyon S. ^{[1
]}

Le, Thalia ^{[1
]}

Sourimant, Julien ^{[2
]}

Yoon, Jeong-Joong ^{[2
]}

Plemper, Richard K. ^{[2
]}

Liotta, Dennis C. ^{[1
]}

机构：

[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA

[2] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA

来源：

ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 05期

关键词：

RSV; fusion inhibitor; benzimidazole; machine learning; INFECTION; INFLUENZA; MECHANISM;

D O I：

10.1021/acsinfecdis.9b00524

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of five benzimidazole-based compounds were identified using a machine learning algorithm as potential inhibitors of the respiratory syncytial virus (RSV) fusion protein. These compounds were synthesized, and compound 2 in particular exhibited excellent in vitro potency with an EC50 value of 5 nM. This new scaffold was then further refined leading to the identification of compound 44, which exhibited a 10-fold improvement in activity with an EC50 value of 0.5 nM.

引用

页码：922 / 929

页数：8

共 50 条

[31] State of the Art in Respiratory Syncytial Virus Drug Discovery and Development
Cockerill, G. Stuart
Good, James A. D.
Mathews, Neil
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (07) : 3206 - 3227
[32] Respiratory syncytial virus: an overview
Aljabali, Alaa A. A.
Obeid, Mohammad A.
El-Tanani, Mohamed
Tambuwala, Murtaza M.
FUTURE VIROLOGY, 2023, : 595 - 609
[33] An Overview of Respiratory Syncytial Virus
Meng, Jia
Stobart, Christopher C.
Hotard, Anne L.
Moore, Martin L.
PLOS PATHOGENS, 2014, 10 (04)
[34] Revealing the binding mode between respiratory syncytial virus fusion protein and benzimidazole-based inhibitors
Ji, Dingjue
Ye, Wei
Chen, HaiFeng
MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1857 - 1866
[35] A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children
Nicholson, Erin G.
Munoz, Flor M.
CLINICAL THERAPEUTICS, 2018, 40 (08) : 1268 - 1281
[36] Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
Sastry, Mallika
Zhang, Baoshan
Chen, Man
Joyce, M. Gordon
Kong, Wing-Pui
Chuang, Gwo-Yu
Ko, Kiyoon
Kumar, Azad
Silacci, Chiara
Thom, Michelle
Salazar, Andres M.
Corti, Davide
Lanzavecchia, Antonio
Taylor, Geraldine
Mascola, John R.
Graham, Barney S.
Kwong, Peter D.
PLOS ONE, 2017, 12 (10):
[37] Optimization of Potent and Selective Quinazolinediones: Inhibitors of Respiratory Syncytial Virus That Block RNA-Dependent RNA-Polymerase Complex Activity
Matharu, Daljit S.
Flaherty, Daniel P.
Simpson, Denise S.
Schroeder, Chad E.
Chung, Donghoon
Yan, Dan
Noah, James W.
Jonsson, Colleen B.
White, E. Lucile
Aube, Jeffrey
Plemper, Richard K.
Severson, William E.
Golden, Jennifer E.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (24) : 10314 - 10328
[38] Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors
Piras, Sandra
Sanna, Giuseppina
Carta, Antonio
Corona, Paola
Ibba, Roberta
Loddo, Roberta
Madeddu, Silvia
Caria, Paola
Aulic, Suzana
Laurini, Erik
Fermeglia, Maurizio
Pricl, Sabrina
FRONTIERS IN CHEMISTRY, 2019, 7
[39] Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus Polymerase
Oraby, Ahmed K.
Bilawchuk, Leanne
West, Frederick G.
Marchant, David J.
ACS OMEGA, 2024, 9 (20): : 22213 - 22229
[40] The adult respiratory syncytial virus The Respiratory Syncytial Virus (RSV) in Adults
Frenzen, F.
Mueller, G.
Frenzen, K.
PNEUMOLOGIE, 2020, 74 (06): : 374 - 386

← 1 2 3 4 5 →